Publication
[Anti-inflammatory drugs and prostatic carcinoma: current state of evidence]
Journal Paper/Review - Mar 27, 2012
Schmid Hans-Peter, Engeler Daniel, Theiler R
Units
PubMed
Doi
Contact
Citation
Type
Journal
Publication Date
Issn Electronic
Pages
Brief description/objective
The epidemiological evidence for a protective effect of anti-inflammatory drugs against prostatic carcinoma is suggestive but not conclusive. Studies are limited by inadequate information on dose and duration of use and by methodological biases. Furthermore, potential benefits should be weighed against the known side effects of long-term use.